Resultados de la búsqueda 751-760 of 2214 for GLP-1 secretion
... 1 (NF1). Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation. Rochester, Minn. The purpose of this study is to ...
... (1 week after surgery). Patient Derived Preclinical Models. Rochester, Minn. The objective of this study is to collect tumor specimens (tumor tissues, matched ...
Diagnóstico. Para ayudar a diagnosticar el trastorno de ansiedad generalizada, el médico o el profesional de salud mental podrían:.
The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...
We hypothesize that hemodynamically significant "asymptomatic" carotid disease may represent one of the few examples of treatable causes of cognitive impairment ...
Rochester, Minn. This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is ...
The aim of this study is to study the efficacy and safety of our short and long one-day protocols for TMP-SMX graded administration in hematologic ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median follow-up 8.5 years). A ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?